Statistics for Immunovant (id:7605 IMVT)

Valuation metrics

Market cap

3.91B

Enterprise value

3.44B

Trailing P/E (ttm)

-14.29

Forward P/E

-8.79

PEG ratio

-8.79

Price/Sales (ttm)

Price/Book (mrq)

8.69

Enterprise Value/Revenue

Enterprise Value/EBITDA

-9.76

Overview

Shares outstanding

146.78M

Float

65.67M

Shares short

13.10M

% Held by insiders

0.56%

% Held by institutions

0.55%

Average volume (10 days)

894.95K

Average volume (90 days)

Price summary

52-Week low

24.61

52-Week high

45.58

52-Week change

-24.82%

Beta

0.71

50-Day moving average

29.45

200-Day moving average

30.13

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

March 31th, 2024

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-54.54%

Return on equity

-92.17%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-352,164,992.00

Net income to common (ttm)

-323,006,016.00

Diluted EPS (ttm)

-2.21

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

472.94M

Total cash per share (mrq)

3.22

Total debt (mrq)

47.00K

Total Debt/Equity (mrq)

0.01

Current ratio (mrq)

761.20%

Book value per share (mrq)

3.06

Cash flow

Cash flow statement

-271,643,008.00

Levered free cash flow (LFCF)

-160,827,008.00